Usefulness of [123I] MIBG myocardial scintigraphy for differential diagnosis of Alzheimer's disease and dementia with Lewy bodies

Internal Medicine

Volumn 42, Issue 10, 2003, Pages 917-918

  Kitagawa, Yasuhisa ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Dementia; Dementia with Lewy bodies; Parkinson's disease; 123I MIBG myocardial scintigraphy

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE 123; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ALZHEIMER DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DRUG TRANSPORT; DRUG UPTAKE; EDITORIAL; HEART SCINTISCANNING; HUMAN; PARKINSON DISEASE; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; HEART; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; ALZHEIMER DISEASE; DIAGNOSIS, DIFFERENTIAL; HEART; HUMANS; LEWY BODY DISEASE; RADIOPHARMACEUTICALS;

EID: 0242522129     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.917     Document Type: Editorial

References (11)

1. 123I] iodobenzylguanidine. J Nucl Med 21: 349-353, 1980.
2. Wieland DM, Brown IE, Rogers WL, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 22: 22-31, 1981.
3. Stanton MS, Tuli MM, Radtke NL, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123 metaiodobenzylguanidine. J Am Coll Cardiol 14: 1519-1526, 1989.
4. Takatsu H, Nishida H, Matsuo H, et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 41: 71-77, 2000.
5. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 67: 189-194, 1999.
6. Druschky A, Hilz MJ, Platsch G, et al. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-Spect. J Neurol Sci 175: 3-12, 2000.
7. 123I] MIBG separates Parkinson's disease from multiple system atrophy. Neurology 53: 1020-1025, 1999.
8. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113-1124, 1996.
9. 123I] MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 71: 583-588, 2001.
10. 123I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease. J Neurol Neurosurg Psychiatry 70: 781-783, 2001.
11. 123I] MIBG) myocardial scintigraphy in differentiating between Alzheimer's disease and dementia with Lewy bodies. Intern Med 42: 686-690, 2003.